-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GE3V1wlicrZlAGw3Sd6wnb82tYhQUXwj5PyeFbw3uvJvjkXbV4SG2aSrc8LPQG1v R6Ct/ewG7bqMdoQ2OorGdQ== 0000849043-08-000093.txt : 20080729 0000849043-08-000093.hdr.sgml : 20080729 20080729170338 ACCESSION NUMBER: 0000849043-08-000093 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20080725 FILED AS OF DATE: 20080729 DATE AS OF CHANGE: 20080729 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SIMON JOHN CENTRAL INDEX KEY: 0001048638 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-18311 FILM NUMBER: 08976483 MAIL ADDRESS: STREET 1: 711 FIFTH AVE CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEUROGEN CORP CENTRAL INDEX KEY: 0000849043 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222845714 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 NORTHEAST INDUSTRIAL RD CITY: BRANFORD STATE: CT ZIP: 06405 BUSINESS PHONE: 2034888201 MAIL ADDRESS: STREET 1: 35 NORTHEAST INDUSTRIAL RD CITY: BRANFORD STATE: CT ZIP: 06405 4 1 edgar.xml PRIMARY DOCUMENT X0303 4 2008-07-25 0000849043 NEUROGEN CORP NRGN 0001048638 SIMON JOHN 35 NORTHEAST INDUSTRIAL ROAD BRANFORD CT 06405 1 0 0 0 Common Stock, par value $0.025 per share 2008-07-25 4 C 0 249990 A 308494 D Series A Exchangeable Preferred Stock 2008-07-25 4 C 0 9615 0 D Common Stock 249990 0 D On April 11, 2008, the Reporting Person purchased 9,615 shares of Series A Exchangeable Preferred Stock, par value $0.025 per share (the "Exchangeable Preferred Stock"), of Neurogen Corporation (the "Company"), which was exchangeable for 26 shares of Common Stock of the Company, (determined by dividing (1) the stated value of the Exchangeable Preferred Stock of $31.20 per share by (ii) the $1.20 exchange price of the Exchangeable Preferred Stock then in effect). On July 25, 2008, the Company's stockholders approved the exchange of the Exchangeable Preferred Stock for shares of Common Stock, which exchange became automatically effective upon receipt of such stockholder approval. The Exchangeable Preferred Stock had no expiration date. Stephen Davis, Attorney-in-fact 2008-07-29 EX-24 2 simon.htm

                  POWER OF ATTORNEY









 The undersigned hereby appoints Stephen R. Davis, EVP

and Chief Business Officer of Neurogen Corporation, his or her

attorney-in-fact and agent in any and all capacities to execute

for and on his or her behalf filings with the Securities and

Exchange Commission on Forms 3, 4 or 5 pursuant to Section 16

of the Securities and Exchange Act of 1934, as amended, to the

extent that such filings relate to the undersigned's status as

a director or officer of Neurogen Corporation.  The undersigned

further appoints Stephen R. Davis his or her attorneyin fact

and agent to execute any and all amendments to such filings as

such attorney-in-fact and agent deems appropriate.  The

undersigned hereby grants to such attorney-in-fact and agent

full power and authority to do and perform each and every act

necessary or desirable as the undersigned could do in person,

hereby ratifying and confirming all that such attorney in fact

and agent may lawfully do or has done by virtue hereof.



This Power of Attorney shall become effective as of May 6, 2003.





/s/ JOHN SIMON

_____________________________

John Simon

-----END PRIVACY-ENHANCED MESSAGE-----